Careers
Careers
Shape the future of our company
Welcome to the Quotient careers page.
We currently have a wide array of career opportunities available spanning a variety of professional disciplines, including research and development, manufacturing, quality management, commercial planning, and corporate support functions.


Joining Quotient represents a fantastic opportunity to become part of a team that will shape the future of the company and contribute to efforts to fundamentally transform transfusion diagnostics. If you want to take the next step in your career in a thriving, positive, and collegiate environment, Quotient could be the place for you.

Explore our Organization

Explore our Organization

Have you ever wondered what it is like to work as a member of a cutting-edge team?

Working at Quotient may well be unlike any other job in the world. There’s so much on offer. Innovation. Scientific breakthroughs. New product development and production growth. Lifesaving technology. Not to mention amazing personal and career development opportunities and the staff association nights. Interested?
Learn more

Life at Quotient

We are committed to delivering solutions that drive continual improvement; as such, we incessantly rethink the way in-vitro diagnostics is practiced. Discover what life is like as a member of the Quotient team.
Learn more
Life at Quotient

Love what we do

1
2
3
4

Available positions

Job title
Department
Location
Trainee Production Operator
Production
Edinburgh, United Kingdom
Laboratory Technician (6 months contract)
Product Development
Eysins, Switzerland
View all jobs

Our Hiring Process

Learn how to apply, review resume and interview tips and get answers to frequently asked questions.
Learn more

Latest updates

News
News
Ein Ehemaliger will es wissen

Quotient Das Startup bringt den ersten in der Schweiz  produzierten Antikörpertest  auf den Markt. Dahinter steckt ein Ex-Roche-Manager.

Test
News
Quotient Limited and hVIVO Announce Partnership to Support Wide-Spread COVID-19 Antibody Testing in the UK

JERSEY, Channel Islands, May 11, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, headquartered in Eysins, Switzerland, and hVIVO, part of Open Orphan plc (LONDON:ORPH), today announced that the MosaiQ™ by Quotient system and MosaiQ

talkRadio with Mike Graham
News
Quotient CEO Franz Walt on talkRADIO with Mike Graham

Quotient CEO Franz Walt was interviewed on 05 May 2020 by Mike Graham on talkRADIO. They discussed the recently CE marked MosaiQ COVID-19 Antibody microarray, antibody testing, and the global COVID-19 pandemic. 

 

CE mark COVID-19 Microarray
News
Quotient Limited Announces CE Mark for its SARS-CoV-2 (COVID-19) Antibody Microarray

JERSEY, Channel Islands, 1 May, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland, today announced that it has completed the process for declaring conformity to the essential requirements of the In V

Quotient
News
Quotient Limited Announces SARS-CoV-2 (COVID-19) Antibody Test Final Performance Data

JERSEY, Channel Islands, April 27, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland, today reported very strong final study performance data for its SARS-CoV-2 antibody test.

COVID-19
News
Quotient Limited Announces SARS-CoV-2 (COVID-19) Antibody Test Performance Update

JERSEY, Channel Islands, April 21, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland, today reported positive performance data for its SARS-CoV-2 antibody test.

View all